Myostatin regulates cell survival during C2C12 myogenesis

R Ríos, I Carneiro, VM Arce, J Devesa - Biochemical and biophysical …, 2001 - Elsevier
R Ríos, I Carneiro, VM Arce, J Devesa
Biochemical and biophysical research communications, 2001Elsevier
During the myogenic process in vitro, proliferating myoblasts withdraw irreversible from the
cell cycle, acquire an apoptosis-resistant phenotype, and fuse into mature myotubes. The
key factor regulating both myocyte cell cycle exit and viability during this transition is the the
cyclin-dependent kinase inhibitor p21cip1. Here we show that the expression of myostatin, a
TGF-β superfamily member known to act as a negative regulator of muscle growth, is
upregulated in the course of C2C12 cells myogenesis. We also show that transient …
During the myogenic process in vitro, proliferating myoblasts withdraw irreversible from the cell cycle, acquire an apoptosis-resistant phenotype, and fuse into mature myotubes. The key factor regulating both myocyte cell cycle exit and viability during this transition is the the cyclin-dependent kinase inhibitor p21cip1. Here we show that the expression of myostatin, a TGF-β superfamily member known to act as a negative regulator of muscle growth, is upregulated in the course of C2C12 cells myogenesis. We also show that transient transfection of C2C12 myobasts with an expression vector encoding mouse myostatin cDNA efficiently inhibits cell proliferation. Paradoxically, myostatin cDNA overexpression also enhances the survival of differentiating C2C12 myocytes, probably by a mechanism involving, at least in part, upregulation of p21cip1 mRNA. Our results suggest that myostatin role in myogenesis is more complex than initially suggested and involves another level of regulation apart from inhibition of myoblast proliferation.
Elsevier